title: Successful adalimumab treatment of HLA B27 negative heel enthesitis documented with MRI and US.
authors.forename: Luana
authors.initials: L
authors.lastname: Mancarella
authors.forename: Milva
authors.initials: M
authors.lastname: Battaglia
authors.forename: Olga
authors.initials: O
authors.lastname: Addimanda
authors.forename: Patrizia
authors.initials: P
authors.lastname: Pelotti
authors.forename: Stefano
authors.initials: S
authors.lastname: Galletti
authors.forename: Riccardo
authors.initials: R
authors.lastname: Meliconi
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002111:Calcaneus / Q000000981:diagnostic imaging / Q000473:pathology; D015796:HLA-B27 Antigen / Q000235:genetics; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D025241:Spondylarthritis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome; D014463:Ultrasonography; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D015796:HLA-B27 Antigen; D000068879:Adalimumab